Stephens Inc Guardant Health, Inc. Transaction History

Stephens Inc

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$21.58 - $29.5 $9,948 - $13,599	-461 Reduced 3.92%	11,285 $305,000
Q3 2023 Nov 14, 2023	BUY	$25.8 - $39.97 $70,846 - $109,757	2,746 Added 30.51%	11,746 $348,000
Q2 2023 Aug 14, 2023	BUY	$20.94 - $38.01 $188,460 - $342,090	9,000 New	9,000 $322,000
Q3 2022 Nov 02, 2022	SELL	$43.66 - $61.0 $9,037 - $12,627	-207 Reduced 3.02%	6,647 $358,000
Q2 2022 Aug 03, 2022	SELL	$28.82 - $77.35 $11,499 - $30,862	-399 Reduced 5.5%	6,854 $276,000
Q1 2022 May 04, 2022	SELL	$48.25 - $100.49 $41,688 - $86,823	-864 Reduced 10.64%	7,253 $480,000
Q4 2021 Mar 07, 2022	SELL	$88.71 - $120.43 $164,557 - $223,397	-1,855 Reduced 18.6%	8,117 $812,000
Q3 2021 Oct 27, 2021	SELL	$98.77 - $132.17 $166,427 - $222,706	-1,685 Reduced 14.45%	9,972 $1.25 Million
Q2 2021 Aug 12, 2021	BUY	$109.77 - $165.68 $125,137 - $188,875	1,140 Added 10.84%	11,657 $1.45 Million
Q1 2021 May 14, 2021	SELL	$127.04 - $179.1 $265,640 - $374,498	-2,091 Reduced 16.58%	10,517 $1.61 Million
Q4 2020 Feb 10, 2021	BUY	$99.96 - $135.93 $89,764 - $122,065	898 Added 7.67%	12,608 $1.63 Million
Q3 2020 Nov 13, 2020	BUY	$80.32 - $111.8 $129,154 - $179,774	1,608 Added 15.92%	11,710 $1.31 Million
Q2 2020 Aug 24, 2020	BUY	$60.49 - $97.5 $7,319 - $11,797	121 Added 1.21%	10,102 $820,000
Q1 2020 May 14, 2020	BUY	$59.04 - $88.81 $589,278 - $886,412	9,981 New	9,981 $695,000

324

127M

844K

2.38M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $4.83B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Stephens Inc , based on Form 13F filings with the SEC.

Stay updated on Stephens Inc with notifications on news.